Is ravulizumab the new treatment of choice for atypical hemolytic uremic syndrome (aHUS)?
Jan Menne
Topics & Concepts
Atypical hemolytic uremic syndromeMedicineImmunologyAntibodyComplement systemComplement system in diseasesRenal Diseases and GlomerulopathiesAdenosine and Purinergic Signaling